(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 16.85% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.98%.
Glaukos's revenue in 2026 is $690,332,000.On average, 16 Wall Street analysts forecast GKOS's revenue for 2026 to be $41,761,023,910, with the lowest GKOS revenue forecast at $39,706,892,521, and the highest GKOS revenue forecast at $43,391,897,679. On average, 16 Wall Street analysts forecast GKOS's revenue for 2027 to be $51,471,086,496, with the lowest GKOS revenue forecast at $46,387,259,301, and the highest GKOS revenue forecast at $55,640,322,050.
In 2028, GKOS is forecast to generate $66,122,903,790 in revenue, with the lowest revenue forecast at $53,632,956,189 and the highest revenue forecast at $82,461,239,910.